In Brief: Pharmacia & Upjohn's Estring
Executive Summary
Pharmacia & Upjohn's Estring: Extended-release estradiol insert is "approvable" effective Sept. 29. Estring would deliver a 2 mg dose of estradiol for treatment of urogenital complications due to estrogen deficiency in postmenopausal women. Pharmacia highlighted the product after announcement of its merger with Upjohn...